AI-based Clinical Trials Solution Provider Market - Global Industry Analysis

Name: AI-based Clinical Trials Solution Provider Market - By Application (Oncology, Metabolic Diseases, and Cardiovascular Diseases), By End-User (Pharmaceutical and Academia), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028
Brand: Zion Market Research
SKU: ZMR-6801
Price: 4199.00 USD
Availability: InStock
Rating: 4.4 (89 reviews)

AI-based Clinical Trials Solution Provider Market - By Application (Oncology, Metabolic Diseases, and Cardiovascular Diseases), By End-User (Pharmaceutical and Academia), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 28-Oct-2021 Category: Healthcare Report Format : PDF Pages: 168 Report Code: ZMR-6801 Status : Published

AI-based Clinical Trials Solution Provider Market accrued earnings worth approximately 1.32 (USD Billion) in 2020 and is predicted to gain revenue of about 5.53(USD Billion) by 2028, is set to record a CAGR of nearly 22.1% over the period from 2021 to 2028.

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

The global AI-based Clinical Trials Solution Provider Market accrued earnings worth approximately 1.32 (USD Billion) in 2020 and is predicted to gain revenue of about 5.53(USD Billion) by 2028, is set to record a CAGR of nearly 22.1% over the period from 2021 to 2028. The report offers assessment and analysis of the AI-based Clinical Trials Solution Provider Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

AI-based Clinical Trials Solution Provider Market: Synopsis

Healthcare industry is one of the major domains which finds plethora of AI applications. Moreover, use of AI in healthcare industry is supported by big data of electronic health records and improved computational ability of AI applications. Nevertheless, AI-based Clinical Trials Solution provider, which is one of the key AI applications, also aids in effective clinical decision making process and enhances new drug molecule discoveries for treating chronic and infectious ailments such as COVID-19, Avian Flu, and Swine Flu. Clinical development is likely to witness a paradigm shift with converging of large online data sources and computing power that helps in determining clinically similar & meaningful trends in data with help of AI algorithms.

Reportedly, AI tools such as AI-based Clinical Trials Solution helps in detecting, diagnosing, treating, and predicting outcomes of chronic ailments including cardiac problems, cancer, neurological ailments, and pathological disorders. According to NCBI, in the timespan between 2000 to 2015, it was found that success proportion of clinical trials conducted on candidates was very low. For instance, only 14% of subjects were successful in all three phases of clinical trials. However, with use of AI in clinical trials, there was a steep reduction in cycle time of trials and improvement in clinical trial outcomes. Such moves are set to accurately and seamlessly address issues related to clinical investigations along with augmenting popularity of AI-based clinical trials solutions. This will boost AI-based Clinical Trials Solution provider market trends.

Global AI-based Clinical Trials Solution Provider Market

AI-based Clinical Trials Solution Provider Market: Growth Dynamics

Growth of AI-based Clinical Trials Solution provider market is subject to massive use of AI & deep learning algorithms in clinical trials for constant streaming of clinical test data for purpose of coding and storing. Apparently, use of AI-driven programs in clinical trials facilitates reduction of human intervention in data collection, thereby resulting in minimal error probability and seamless integration of clinical data with other databases. This will amplify scope of AI-based Clinical Trials Solution provider industry. Furthermore, use of AI-driven health systems & patient support tools are set to aid clinical trials, thereby engaging and retaining subjects throughout all phases of clinical trials. Moreover, AI-driven clinical trial solution providers assist in virtual monitoring of candidate condition and thus mitigate in-person visit to clinical trial site. Apart from this, use of AI technologies by healthcare & biotech firms helps the latter in sending of reminders & informing clinical trial progress to candidates. In addition to this, AI-based Clinical Trials Solution provider makes use of AI-driven search tools for detecting type of clinical trials through querying of clinical data of candidates.

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companies upon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact research needs.

For the record, firms such as AiCure and Brite Health are making use of AI-based systems for monitoring patient health as well as their responses to medical treatment during clinical tests. Furthermore, these firms ensure efficiency of medical treatment and adherence to clinical trial procedures along with patient retention for completion of clinical trials. All these strategic moves will proliferate growth in size of AI-based Clinical Trials Solution provider market over forthcoming years.

Regional Landscape

North America To Lead Overall Market Growth By 2028

Growth of AI-based Clinical Trials Solution market in North America over assessment period can be attributed to various factors. Some of them include increase in acceptance of AI-driven systems in healthcare industry, rise in precision medicine practices & applications, and coining of strategy focusing on co-developing precision diagnostics and therapeutic agents as companion diagnostics for facilitating launch of effective drugs to successfully treat patients suffering from chronic ailments. In addition to this, startup firms such as Unlearn.ai based in San Francisco are highlighting on minimizing number of subjects for clinical trials through use of AI-based tools. Apparently, third party service providers including antidote.me, Deep 6 AI, and Trials. Ai based in the U.S. have created AI apps that helps in identifying & recruiting suitable patients for enrollment in clinical trials through exact examination of healthcare records of patients.

Competitive Landscape

Key players impacting industry sphere and profiled in report are Deep 6 AI, Unlearn.AI, Inc., Saama Technologies, Mendel.ai, Antidote Technologies, Inc., Phesi, Innoplexus, Intelligencia, Symphony AI, Median Technologies, Aicure, LLC, BioAge Labs, Inc., DEEP LENS AI, CONSILX, Pharmaseal, Ardigen, Halo Health Systems, Trials.AI, IBM Watson, Koneksa Health, BioSymetrics, Euretos, GNS Healthcare, and Exscientia.

The global AI-based Clinical Trials Solution Provider Market is segmented as follows:

By Application

Cardiovascular Diseases
Oncology
Metabolic Diseases

By End-User

Pharmaceutical
Academia

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodulogy
  - 1.3.1. Market Research Type
  - 1.3.2. Market Research Methodulogy
Chapter 2. Executive Summary
- 2.1. AI-based Clinical Trials Sulution Market, 2018–2028(USD Billion)
- 2.2. AI-based Clinical Trials Sulution Market: Snapshot
Chapter 3. Global AI-based Clinical Trials Sulution Market– Industry Analysis
- 3.1. AI-based Clinical Trials Sulution Market: Market Dynamics
- 3.2. Market Drivers
  - 3.2.1. Soar in latitude of AI-based Clinical Trials Sulution provider market growth is predicted to be due to intensive application of AI & deep learning algorithms in clinical trials for consistently streaming of clinical test data for coding and storing.
  - 3.2.2. Use of AI-driven programs in clinical experiments enables reduction of human intervention in data cullection, thereby leading to possibilities of causing fewer errors. This will improve amplitude of AI-based Clinical Trials Sulution provider industry growth in years to come.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
  - 3.4.1. Market attractiveness analysis By Application
  - 3.4.2. Market attractiveness analysis By End-User
Chapter 4. Global AI-based Clinical Trials Sulution Market– Competitive Landscape
- 4.1. Company market share analysis
  - 4.1.1. Global AI-based Clinical Trials Sulution Market: company market share, 2019
- 4.2. Strategic development
  - 4.2.1. Acquisitions & mergers
  - 4.2.2. New Service launches
  - 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
Chapter 5. Global AI-based Clinical Trials Sulution Market– Application Analysis
- 5.1. Global AI-based Clinical Trials Sulution Provider Market overview: By Application
  - 5.1.1. Global AI-based Clinical Trials Sulution Provider Market share, By Application, 2020 and 2028
- 5.2. Cardiovascular Diseases
  - 5.2.1. Global AI-based Clinical Trials Sulution Provider Marketby Cardiovascular Diseases, 2018–2028(USD Billion)
- 5.3. Onculogy
  - 5.3.1. Global AI-based Clinical Trials Sulution Provider Marketby Onculogy, 2018–2028(USD Billion)
- 5.4. Metabulic Diseases
  - 5.4.1. Global AI-based Clinical Trials Sulution Provider Market by Metabulic Diseases, 2018–2028(USD Billion)
Chapter 6. Global AI-based Clinical Trials Sulution Provider Marketoverview: By End-User
- 6.1.1. Global AI-based Clinical Trials Sulution Provider Marketshare, By End-User, 2020 and 2028
- 6.2. Pharmaceutical
  - 6.2.1. Global AI-based Clinical Trials Sulution Provider Marketby Pharmaceutical , 2018–2028(USD Billion)
- 6.3. Academia
  - 6.3.1. Global AI-based Clinical Trials Sulution Provider Marketby Academia, 2018–2028(USD Billion)
Chapter 7. Company Profiles
- 8. Deep 6 AI
  - 8.1.1. Overview
  - 8.1.2. Financials
  - 8.1.3. Service Portfulio
  - 8.1.4. Business Strategy
  - 8.1.5. Recent Developments
- 8.2. Unlearn.AI, Inc.
  - 8.2.1. Overview
  - 8.2.2. Financials
  - 8.2.3. Service Portfulio
  - 8.2.4. Business Strategy
  - 8.2.5. Recent Developments
- 8.3. Saama Technulogies
  - 8.3.1. Overview
  - 8.3.2. Financials
  - 8.3.3. Service Portfulio
  - 8.3.4. Business Strategy
  - 8.3.5. Recent Development
- 8.4. Mendel.ai
  - 8.4.1. Overview
  - 8.4.2. Financials
  - 8.4.3. Service Portfulio
  - 8.4.4. Business Strategy
  - 8.4.5. Recent Development
- 8.5. Antidote Technulogies, Inc.
  - 8.5.1. Overview
  - 8.5.2. Financials
  - 8.5.3. Service Portfulio
  - 8.5.4. Business Strategy
  - 8.5.5. Recent Development
- 8.6. Phesi
  - 8.6.1. Overview
  - 8.6.2. Financials
  - 8.6.3. Service Portfulio
  - 8.6.4. Business Strategy
  - 8.6.5. Recent Development
- 8.7. Innoplexus
  - 8.7.1. Overview
  - 8.7.2. Financials
  - 8.7.3. Service Portfulio
  - 8.7.4. Business Strategy
  - 8.7.5. Recent Development
- 8.8. Intelligencia
  - 8.8.1. Overview
  - 8.8.2. Financials
  - 8.8.3. Service Portfulio
  - 8.8.4. Business Strategy
  - 8.8.5. Recent Development
- 8.9. Symphony AI
  - 8.9.1. Overview
  - 8.9.2. Financials
  - 8.9.3. Service Portfulio
  - 8.9.4. Business Strategy
  - 8.9.5. Recent Development
- 8.10. Median Technulogies
  - 8.10.1. Overview
  - 8.10.2. Financials
  - 8.10.3. Service Portfulio
  - 8.10.4. Business Strategy
  - 8.10.5. Recent Development
- 8.11. Aicure, LLC
  - 8.11.1. Overview
  - 8.11.2. Financials
  - 8.11.3. Service Portfulio
  - 8.11.4. Business Strategy
  - 8.11.5. Recent Development
- 8.12. Koneksa Health
  - 8.12.1. Overview
  - 8.12.2. Financials
  - 8.12.3. Service Portfulio
  - 8.12.4. Business Strategy
  - 8.12.5. Recent Development
- 8.13. IBM Watson
  - 8.13.1. Overview
  - 8.13.2. Financials
  - 8.13.3. Service Portfulio
  - 8.13.4. Business Strategy
  - 8.13.5. Recent Development
  - 8.14. Trials.AI
  - 8.14.1. Overview
  - 8.14.2. Financials
  - 8.14.3. Service Portfulio
  - 8.14.4. Business Strategy
  - 8.14.5. Recent Development
- 8.15. Halo Health Systems
  - 8.15.1. Overview
  - 8.15.2. Financials
  - 8.15.3. Service Portfulio
  - 8.15.4. Business Strategy
  - 8.15.5. Recent Development
- 8.16. Ardigen
  - 8.16.1. Overview
  - 8.16.2. Financials
  - 8.16.3. Service Portfulio
  - 8.16.4. Business Strategy
  - 8.16.5. Recent Development
- 8.17. Pharmaseal
  - 8.17.1. Overview
  - 8.17.2. Financials
  - 8.17.3. Service Portfulio
  - 8.17.4. Business Strategy
  - 8.17.5. Recent Development
- 8.18. CONSILX
  - 8.18.1. Overview
  - 8.18.2. Financials
  - 8.18.3. Service Portfulio
  - 8.18.4. Business Strategy
  - 8.18.5. Recent Development
- 8.19. DEEP LENS AI
  - 8.19.1. Overview
  - 8.19.2. Financials
  - 8.19.3. Service Portfulio
  - 8.19.4. Business Strategy
  - 8.19.5. Recent Development
- 8.20. BioAge Labs, Inc.
  - 8.20.1. Overview
  - 8.20.2. Financials
  - 8.20.3. Service Portfulio
  - 8.20.4. Business Strategy
  - 8.20.5. Recent Development
- 8.21. Exscientia
  - 8.21.1. Overview
  - 8.21.2. Financials
  - 8.21.3. Service Portfulio
  - 8.21.4. Business Strategy
  - 8.21.5. Recent Development
- 8.22. GNS Healthcare
  - 8.22.1. Overview
  - 8.22.2. Financials
  - 8.22.3. Service Portfulio
  - 8.22.4. Business Strategy
  - 8.22.5. Recent Development
- 8.23. Euretos
  - 8.23.1. Overview
  - 8.23.2. Financials
  - 8.23.3. Service Portfulio
  - 8.23.4. Business Strategy
  - 8.23.5. Recent Development
- 8.24. BioSymetrics
  - 8.24.1. Overview
  - 8.24.2. Financials
  - 8.24.3. Service Portfulio
  - 8.24.4. Business Strategy
  - 8.24.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global AI-based Clinical Trials Solution Marketattractiveness, By Application
6. Global AI-based Clinical Trials Solution Marketattractiveness, By End-User
7. Global AI-based Clinical Trials Solution Marketshare by Application ,2020 and 2028 (USD Billion)
8. Global AI-based Clinical Trials Solution Marketby Cardiovascular Diseases, 2018–2028(USD Billion)
9. Global AI-based Clinical Trials Solution Marketby Oncology, 2018–2028(USD Billion)
10. Global AI-based Clinical Trials Solution Marketby Metabolic Diseases, 2018–2028(USD Billion)
11. Global AI-based Clinical Trials Solution Marketshare by End-User ,2020 and 2028 (USD Billion)
12. Global AI-based Clinical Trials Solution Marketby Pharmaceutical, 2018–2028(USD Billion)
13. Global AI-based Clinical Trials Solution Marketby Academia, 2018–2028(USD Billion)
14. Global AI-based Clinical Trials Solution Marketshare, by Region, 2020 and 2028
15. North America AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
16. Europe AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
17. Asia Pacific AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
18. Latin America AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
19. The Middle East and Africa AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)

Table Of Tables

List of Tables

1. Global AI-based Clinical Trials Solution Market: snapshot
2. Drivers of the AI-based Clinical Trials Solution Market: impact analysis
3. North America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
4. North America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
5. The U.S. AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
6. The U.S. AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
7. Rest of North America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
8. Rest of North America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
9. Europe AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
10. Europe AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
11. UK AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
12. UK AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
13. France AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
14. France AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
15. Germany AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
16. Germany AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
17. Rest of Europe AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
18. Rest of Europe AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
19. Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
20. Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
21. China AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
22. China AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
23. Japan AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
24. Japan AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
25. India AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
26. India AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
27. Rest of Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
28. Rest of Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
29. Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
30. Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
31. Brazil AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
32. Brazil AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
33. Rest of Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
34. Rest of Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
35. The Middle East and Africa AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
36. The Middle East and Africa AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
37. Saudi Arabia AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
38. Saudi Arabia AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
39. South Africa AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
40. South Africa AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)